Psychemedics (NASDAQ:PMD) Share Price Passes Above 200 Day Moving Average – Here’s What Happened

Psychemedics Co. (NASDAQ:PMD)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.34 and traded as high as $2.35. Psychemedics shares last traded at $2.35, with a volume of 18,107 shares changing hands.

Psychemedics Stock Performance

The firm has a fifty day moving average of $2.32 and a 200 day moving average of $2.34. The company has a market capitalization of $13.79 million, a P/E ratio of -3.00 and a beta of 0.65.

Psychemedics (NASDAQ:PMD) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.14) earnings per share (EPS) for the quarter. Psychemedics had a negative net margin of 21.50% and a negative return on equity of 68.43%. The company had revenue of $4.73 million for the quarter.

Psychemedics Company Profile

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol.